Is the Versarien share price still cheap or could it cost you dearly?

G A Chester discusses soaring small-cap Versarien plc (LON:VRS) and a high-flying FTSE 250 (INDEXFTSE:MCX) stock.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I’ve written positively in the past about AIM-listed advanced materials firm Versarien (LSE: VRS) and FTSE 250 media sector group Ascential (LSE: ASCL). The shares of both companies have recently been hitting new highs. Are they still cheap at their current levels or could they cost investors dearly?

Digital economy

Ascential’s shares opened 2.3% lower at 449p this mornings after the £1.8bn mid-cap released its half-year results. Nevertheless, they’re up a healthy 33% over the last 12 months. Management said first-half trading was in line with its expectations and that it “remains confident in our overall 2018 performance and our prospects for continued success.”

Closing net debt at 30 June was £285m but the group has since received a net £284m cash from the disposal of its exhibitions business to ITE. This provides Ascential with headroom to develop its other businesses via organic growth and acquisitions. These businesses are focused on information and analytics, and provide customers with the means “to win in the digital economy by excelling at product design, marketing and sales.”

When I looked at Ascential last summer, the share price was 374p and the forward price-to-earnings (P/E) ratio was 21.4. At today’s share price and on City earnings forecasts of 17p a share, the forward P/E is 26.4. This looks too rich to me for a company expected to grow earnings by 15% from 2018 to 2019 and with it also offering a fairly meagre dividend yield of 1.4%, I rate the stock a ‘sell’ at the current level.

Multiple collaborations

Versarien is currently lossmaking but is a hugely popular stock with private investors. Indeed, the three biggest holdings in the company are represented by the pooled investments of retail clients of Hargreaves Lansdown, Interactive Investor and Halifax Share Dealing.

The group has made five acquisitions since floating on AIM at 12.25p a share in 2013, three of which were revenue-generating at the time. The total acquisition cost for the three was £4.2m and in the year before Versarien bought them their revenues added up to £11.7m. Versarien reported total group revenue of £9m in its latest annual results, released last week. Therefore, I find it hard to value these businesses at much more than the £4.2m Versarien paid for them.

The company’s shares are trading a little down from their recent high of 141p, valuing the group at £210m. As such, I’d say the other two businesses Versarien acquired are being valued at over £200m. It bought 85% of each company, paying £440,000 in one case and £170,000 in the other. These businesses are focused on advanced material graphene and Versarien has announced multiple collaborations and trials with partners in a variety of sectors. However, the agreements are short on detail at this stage, particularly financial detail.

It’s reckoned the industry could be worth $1bn globally by 2025 and my Foolish colleague Rupert Hargreaves believes now could be a good time to buy into Versarien’s growth story. I’ve previously been bullish on the company myself, when the shares could be bought at 10 times current revenue (my upper limit for this kind of stock). However, with the valuation now up to well over 20 times revenue, I see the risk/reward trade-off as having turned unattractive and I’m inclined to rate the stock a ‘sell’.

G A Chester has no position in any of the shares mentioned. The Motley Fool UK has recommended Hargreaves Lansdown. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

Down 15% in a month and yielding 7.5%! Should I buy even more of my favourite dividend stock?

Harvey Jones says this brilliant FTSE 100 dividend stock is suddenly cheaper due to recent market volatility. And the yield…

Read more »

Abstract bull climbing indicators on stock chart
Growth Shares

3 growth shares for an ISA that have beaten the FTSE 100 for the past 5 years

Jon Smith points out several growth shares that have outperformed the broader market over a long period of time, with…

Read more »

Calendar showing the date of 5th April on desk in a house
Investing Articles

Time’s running out for our 2025/26 Stocks and Shares ISA plans!

Never mind the stock market wobble, it's time to turn our attention to our Stocks and Shares ISA investments for…

Read more »

UK financial background: share prices and stock graph overlaid on an image of the Union Jack
Investing Articles

What might Warren Buffett think about today’s stock market?

Middle East conflict has given the UK stock market a bit of a hammering. But in the long-term scheme of…

Read more »

Man riding the bus alone
Dividend Shares

How big does my ISA need to be to make £2.5k in monthly passive income?

Jon Smith points out the key factors that go into building a dividend portfolio for passive income, and reviews one…

Read more »

Friends at the bay near the village of Diabaig on the side of Loch Torridon in Wester Ross, Scotland. They are taking a break from their bike ride to relax and chat. They are laughing together.
Investing Articles

2 UK stocks to consider buying as Mounjaro and Wegovy take off

Weight-loss drugs like Mounjaro are surging in popularity, making the following pair interesting stocks to think about buying today.

Read more »

British union jack flag and Parliament house at city of Westminster in the background
Investing Articles

As the FTSE 100 drops back below 10,000, how long can share prices keep falling?

FTSE 100 share prices are falling, but is it time to consider buying shares in the one industry that’s still…

Read more »

piggy bank, searching with binoculars
Investing Articles

As the stock market closes in on a correction, where are the buying opportunities?

Volatile share prices can bring huge buying opportunities. But which shares offer value with the stock market closer to correction…

Read more »